The United States is seeing a second peak in flu cases this season. After doctor’s office visits for flu dipped early this ...

Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q4 CY2024 results , with sales up 14.6% year on year to ...

Mizuho raised the firm’s price target on Quest Diagnostics (DGX) to $178 from $177 and keeps an Outperform rating on the shares following the ...

Piper Sandler analyst David Westenberg raised the firm’s price target on Quest Diagnostics (DGX) to $180 from $165 and keeps a Neutral rating ...

Following the earnings announcement, Quest Diagnostics (NYSE:DGX)' stock price rose by 0.48% in pre-market trading. The stock ...

Quest Diagnostics is a leading provider of independent diagnostic testing in the United States thanks to its network of roughly 2,300 patient service centers across the country. We think its size and ...

University Hospitals completes sale of about 50 outpatient lab services locations in Ohio to New Jersey-based Quest.

The global organ transplant diagnostics market size was valued at USD 4.95 billion in 2024 and is projected to reach from USD ...

The "Cholesterol Testing Products and Services Market by Product, by Test Cholesterol Tests, by Application, by End-User, and ...

With the acute phase of the Covid-19 pandemic fading even as the coronavirus persists and evolves, a new normal is taking shape around the world. Experts expect cases to rise again this winter.

Here’s the latest on symptoms, treatments and testing. By Dani Blum Dani Blum has reported on Covid since the spring of 2020. There are few constants when it comes to Covid, but one thing has ...

According to Halifax, Nova Scotia-based MedMira, the Reveal HIV test has sensitivity of 99.6 percent and specificity of 99.7 percent. "As the rates of HIV infections continue to rise in Canada, ...